Recombinant IL6 blockers have been successfully applied to treat rheumatoid arthritis (Choy et al., 2002), and this study indicates the need for further investigation into IL6, as a potential target for therapeutic intervention in tendinopathy. Here, IL6 is linked to rheumatoid arthritis.